Neural Stem Cells as Carriers of Nucleoside-Conjugated Nanogels: A New Approach toward Cell-Mediated Delivery
Source abstract
Abstract
Neural stem cells (NSCs) present attractive natural drug delivery systems (DDSs). Their migratory potential enables crossing of the blood-brain barrier and efficient and selective accumulation near malignant cells. Here, we present the potential of NSCs as DDSs for nucleoside analogue-conjugated nanogels (NGs). Two different approaches were investigated: the intracellular loading and extracellular cell surface decoration with NGs. For both designs, the tumor-specific migratory potentials of NSCs remained unchanged; however, the intracellular loading showed a shorter NG retention. The cell surface decoration protocol yielded a high loading capacity of 100% after 1 h and a prolonged drug retention. A redox-sensitive linker between NGs and the nucleoside analogue 5-ethynyl-2'-deoxycytidine (EdC) allowed a tumor environment-specific drug release and its efficient and preferential incorporation into the DNA of the tumor cells. Interestingly, the tumor-trafficking potentials of NSCs were significantly potentiated by irradiation of tumor cells. In conclusion, this study indicates the potentials of cell surface-decorated NSCs as DDSs for tumor-specific release, cellular uptake, and incorporation of EdC into DNA.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Neurogenesis and neuroplasticity mechanisms · RNA Interference and Gene Delivery · MicroRNA in disease regulation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Nuclear Medicine, RWTH Aachen University, 52074 Aachen, Germany
DWI − Leibniz-Institute for Interactive Materials, RWTH Aachen University, 52074 Aachen, Germany
Max Planck Institute for Medical Research, Heidelberg 69120, Germany
Department of Nuclear Medicine, Maastricht University Medical Centre, 6229 HX Maastricht, Netherlands
Funding
Deutsche Forschungsgemeinschaft
References (45)
Show source-provided references
1. 10.1073/pnas.97.23.1284610.1073/pnas.97.23.12846 ↗
2. 10.1038/7471010.1038/74710 ↗
3. 10.1371/journal.pone.000002310.1371/journal.pone.0000023 ↗
4. 10.1002/sctm.16-039710.1002/sctm.16-0397 ↗
5. 10.1038/mt.2008.29010.1038/mt.2008.290 ↗
6. 10.1186/2052-8426-2-3110.1186/2052-8426-2-31 ↗
7. 10.3390/ijms2205225810.3390/ijms22052258 ↗
8. 10.1002/smll.20130111110.1002/smll.201301111 ↗
9. 10.1021/nn505147w10.1021/nn505147w ↗
10. 10.1016/S1470-2045(02)00788-X10.1016/S1470-2045(02)00788-X ↗
11. Chen W. · J. Nucl. Med. · 2005 · 46 · 946
12. 10.1016/S0360-3016(97)00770-010.1016/S0360-3016(97)00770-0 ↗
13. Dupertuis Y. M. · Cancer Res. · 2001 · 61 · 7971
14. Kassis A. I. · Q J. Nucl. Med. · 1996 · 40 · 301
15. 10.1158/1078-0432.CCR-08-090710.1158/1078-0432.CCR-08-0907 ↗
16. 10.18632/oncotarget.212310.18632/oncotarget.2123 ↗
17. 10.1002/smll.20170409310.1002/smll.201704093 ↗
18. 10.1038/nn117210.1038/nn1172 ↗
19. 10.1016/j.ajpath.2017.08.03110.1016/j.ajpath.2017.08.031 ↗
20. 10.1038/nnano.2013.2310.1038/nnano.2013.23 ↗
21. 10.1016/j.biomaterials.2009.09.06010.1016/j.biomaterials.2009.09.060 ↗
22. 10.1016/j.biomaterials.2015.03.00110.1016/j.biomaterials.2015.03.001 ↗
23. 10.1523/JNEUROSCI.08-04-01144.198810.1523/JNEUROSCI.08-04-01144.1988 ↗
24. 10.1371/journal.pone.023461410.1371/journal.pone.0234614 ↗
25. 10.1038/nm.219810.1038/nm.2198 ↗
26. 10.1021/acsabm.0c0161910.1021/acsabm.0c01619 ↗
27. 10.3389/fragi.2021.69068610.3389/fragi.2021.690686 ↗
28. 10.2174/138161282166615030211390610.2174/1381612821666150302113906 ↗
29. 10.1155/2021/850202110.1155/2021/8502021 ↗
30. 10.2967/jnumed.115.16300610.2967/jnumed.115.163006 ↗
31. 10.5966/sctm.2013-004910.5966/sctm.2013-0049 ↗
32. 10.2217/fon.13.21710.2217/fon.13.217 ↗
33. Roelcke U. · J. Nucl. Med. · 2002 · 43 · 1444
34. 10.1002/adhm.20210081210.1002/adhm.202100812 ↗
35. 10.1124/mol.59.5.118110.1124/mol.59.5.1181 ↗
36. 10.1158/1078-0432.CCR-09-315110.1158/1078-0432.CCR-09-3151 ↗
37. 10.1039/C7RA10151A10.1039/C7RA10151A ↗
38. 10.3390/cancers1105068810.3390/cancers11050688 ↗
39. 10.1016/j.ymeth.2011.06.00910.1016/j.ymeth.2011.06.009 ↗
40. 10.1002/stem.54310.1002/stem.543 ↗
41. 10.1002/glia.2032610.1002/glia.20326 ↗
42. 10.1002/1439-2054(20020401)287:4<223::AID-MAME223>3.0.CO;2-Z10.1002/1439-2054(20020401)287:4<223::AID-MAME223>3.0.CO;2-Z ↗
43. 10.1016/j.msec.2017.02.08810.1016/j.msec.2017.02.088 ↗
44. 10.1002/advs.20180061410.1002/advs.201800614 ↗
45. 10.1016/j.ab.2011.05.03710.1016/j.ab.2011.05.037 ↗